Saranas

📍 Houston, United States🗓 Founded 2013👥 12 employees💰 Last funded Aug 2022
Medical Equipment Manufacturing🌐 saranas.com
Website LinkedIn
Saranas has developed a technology that allows for the early detection and monitoring of bleeding complications associated with vascular access procedures. The Early Bird Bleed Monitoring System includes a vascular access sheath with embedded sensors that measure the electrical resistance across the blood vessel. By sensing a change in the vessel’s electrical resistance, the Early Bird is designed to detect and monitor bleeding from a blood vessel accidentally injured during endovascular procedures, such as transcatheter aortic valve replacement, large bore hemodynamic support device placement, or other complex cardiac interventions, where the femoral artery or vein is used to gain vascular access to the heart. The technology was invented at the Texas Heart Institute.
1
Total investors
0
Early stage
0
Mid stage
1
Late stage
2013
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Saranas?
Saranas has 1 investors on record on gritt.io and 1 late-stage investors.
When did Saranas last raise funding?
The most recent investment in Saranas recorded on gritt.io was in August 2022.
When was Saranas founded?
Saranas was founded in 2013.
What industry is Saranas in?
Saranas operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.
Where is Saranas based?
Saranas is headquartered in Houston, United States.